BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 19/01/2011

FDA Withdraws ALBAMYCIN Capsule from Sale Due to Safety Concerns

The US Food and Drug Administration has withdrawn ALBAMYCIN (novobiocin sodium) 250mg capsules from sale, citing safety concerns, and will not accept new applications for this medication.

Source: Federal Register — Health and Human ServicesOpen original release →